The direction of Isc inflection following bumetanide differed between the CF and non-CF subjects, likely reflecting the nature of the dominant operative ion transport pathway that was sensitive to bumetanide (CFTR-dependent Cl- secretion in non-CF subjects, K+ secretion in CF). The gene discussed is CFTR; the disease is cystic fibrosis.